Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world setting. (Q41699194)
Jump to navigation
Jump to search
scientific article published on 15 May 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world setting. |
scientific article published on 15 May 2015 |
Statements
Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world setting (English)
Marion Sassier
Audrey Emmanuelle Dugué
Bénédicte Clarisse
Virginie Avrillon
Acya Bizieux-Thaminy
Jean-Bernard Auliac
Laure Kaluzinski
Julie Tillon
Gilles Robinet
Isabelle Monnet
Anne Madroszyk
Gabriella Boza
Lionel Falchero
Pierre Fournel
Thomas Egenod
Anne-Claire Toffart
Nathalie Leiber
Pascal Do
Radj Gervais